BioMed Realty’s $720 Million sale of the Landmark at Eastview Property

Simpson Thacher is representing affiliates of BioMed Realty, L.P., in connection with its proposed sale of The Landmark at Eastview property to Regeneron Pharmaceuticals, Inc. (NASDAQ:…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here